Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force

1

  • 1U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland, USA.

Insights

The U.S. Preventive Services Task Force found insufficient evidence to recommend novel risk factors for screening coronary heart disease (CHD) in asymptomatic individuals. More research is needed to determine benefits and harms for preventing CHD events.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Risk Assessment

Background:

  • The U.S. Preventive Services Task Force (USPSTF) evaluated novel risk factors for coronary heart disease (CHD) in asymptomatic individuals.
  • Traditional risk assessment for CHD often relies on factors like the Framingham score.

Purpose of the Study:

  • To assess the utility of nine nontraditional CHD risk factors in refining risk stratification for asymptomatic individuals.
  • To determine if these novel markers can effectively reclassify intermediate-risk individuals to high- or low-risk strata for targeted interventions.

Main Methods:

  • Conducted systematic literature reviews of studies published since 1996 on nine proposed nontraditional CHD risk markers.
  • Included high-sensitivity C-reactive protein, ankle-brachial index, leukocyte count, fasting blood glucose, periodontal disease, carotid intima-media thickness, coronary artery calcification, homocysteine, and lipoprotein(a).
  • Employed a hierarchical approach to evaluate the practical and definitive reassignment capabilities of these markers.

Main Results:

  • Evidence was reviewed for nine nontraditional markers: hs-CRP, ABI, WBC, glucose, periodontal disease, CIMT, CAC, homocysteine, Lp(a).
  • The goal was to see if these markers could effectively reclassify individuals from intermediate to high or low CHD risk.
  • The hierarchical approach aimed to identify markers with practical and definitive reassignment capabilities.

Conclusions:

  • The USPSTF concluded that current evidence is insufficient to assess the benefits and harms of using these novel risk factors for screening.
  • This applies to asymptomatic men and women with no prior history of CHD.
  • Further research is required to establish the role of these markers in preventing CHD events.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...